Kalydeco


Indications and Reactions:

Role Indications Reactions
Primary
Cystic Fibrosis 84.4%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 2.9%
Malabsorption 2.4%
Cystic Fibrosis Lung 1.5%
Pancreatic Insufficiency 1.2%
Renal Colic 1.2%
Dyspepsia 0.9%
Attention Deficit/hyperactivity Disorder 0.6%
Cystic Fibrosis Related Diabetes 0.6%
Diabetes Mellitus 0.6%
Gastrooesophageal Reflux Disease 0.6%
Migraine 0.6%
Upper Respiratory Tract Infection 0.6%
Bacterial Disease Carrier 0.3%
Bronchopulmonary Aspergillosis Allergic 0.3%
Constipation 0.3%
Contraception 0.3%
Convulsion 0.3%
Infection 0.3%
Insomnia 0.3%
Drug Ineffective 14.8%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 11.1%
Cough 8.3%
Headache 6.5%
Nasopharyngitis 6.5%
Constipation 4.6%
Off Label Use 4.6%
Weight Increased 4.6%
Blood Glucose Increased 3.7%
Liver Function Test Abnormal 3.7%
Oropharyngeal Pain 3.7%
Pulmonary Function Test Decreased 3.7%
Rash 3.7%
Transaminases Increased 3.7%
Abdominal Pain Upper 2.8%
Chest Pain 2.8%
Diarrhoea 2.8%
Dizziness 2.8%
Exposure During Pregnancy 2.8%
Hypoglycaemia 2.8%
Secondary
Cystic Fibrosis 45.7%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 13.0%
Large Intestinal Ulcer 13.0%
Cystic Fibrosis Lung 10.9%
Pancreatic Insufficiency 8.7%
Constipation 2.2%
Gastrooesophageal Reflux Disease 2.2%
Insomnia 2.2%
Lymphoma 2.2%
Urticaria 31.6%
Wheezing 10.5%
Drug Level Increased 5.3%
Dry Mouth 5.3%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 5.3%
Lip Swelling 5.3%
Off Label Use 5.3%
Rhabdomyolysis 5.3%
Transaminases Increased 5.3%
Type Iv Hypersensitivity Reaction 5.3%
Viral Infection 5.3%
Vomiting 5.3%
Weight Decreased 5.3%

Drug Data